Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02618382 · ClinicalTrials.gov registry record · Phase 4
A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population
A Phase 4 study, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT02618382 is a Phase 4 study that has completed, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 32 participants.
The verdict
NCT02618382, a Phase 4 study, has completed, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a single center single arm study of 50 patients to 1) determine the safety of tranexamic acid in the chronic subdural hematoma population following surgical drainage of chronic subdural hematomas and 2) determine if the use of oral tranexamic acid reduces the rate of ipsilateral recurrence following drainage of chronic subdural hematomas. This will be compared to historical controls. This study intends to be a prerequisite to a large nationally funded randomized control trial.
Interventions
- DRUG Tranexamic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-11-01 |
| Est. Completion | 2018-06-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02618382
The ClinicalTrials.gov registry entry for NCT02618382 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tranexamic Acid is the first listed.
NCT02618382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02618382 about?
NCT02618382 is a clinical study titled "A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population". This is a single center single arm study of 50 patients to 1) determine the safety of tranexamic acid in the chronic subdural hematoma population following surgical drainage of chronic subdural hematomas and 2) determine if the use of oral tranexamic acid reduces the rate of ipsilateral recurrence f...
What is the current status of trial NCT02618382?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2015-11-01. Estimated completion is 2018-06-12.
What interventions are being tested in trial NCT02618382?
The interventions under investigation include: Tranexamic Acid (DRUG).
Who is sponsoring clinical trial NCT02618382?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.